Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasimudeen R Jabir

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Design|December 10, 2015
Cardiovascular disease management through restrained inflammatory responsesNasimudeen R Jabir, Shams Tabrez
Seminars in Cancer Biology|June 22, 2017
An insight on the association of glycation with hepatocellular carcinomaNasimudeen R Jabir, Saheem Ahmad, Shams Tabrez
CNS Neuroscience & Therapeutics|May 18, 2018
Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's diseaseNasimudeen R Jabir, Fayaz Rahman Khan, Shams Tabrez
Journal of Drug Targeting|February 19, 2019
The role of mitochondrial defects and oxidative stress in Alzheimer's diseaseBadar Ul Islam, Nasimudeen R Jabir, Shams Tabrez
Molecular Biology Reports|January 13, 2022
Association of IL-6 promoter polymorphism hotspots (- 174G/C and - 572G/C) with cardiovascular disease risk factorsShams Tabrez, Nasimudeen R Jabir, Torki A Zughaibi, et al.
Molecular Biology Reports|August 25, 2021
Genotyping of interleukins-18 promoters and their correlation with coronary artery stenosis in Saudi populationShams Tabrez, Nasimudeen R Jabir, Torki A Zughaibi, et al.
Critical Reviews in Eukaryotic Gene Expression|November 4, 2019
Association of Plasma Fibrinogen Level with Insulin Resistance in Angiographically Confirmed Coronary Artery Disease PatientsShams Tabrez, Nasimudeen R Jabir, Shazi Shakil, et al.
Biological Chemistry|May 5, 2021
Identification of novel cardiovascular disease associated metabolites using untargeted metabolomicsShams Tabrez, Mohammed Razeeth Shait Mohammed, Nasimudeen R Jabir, et al.
CNS & Neurological Disorders Drug Targets|January 11, 2012
C-peptide and its correlation to parameters of insulin resistance in the metabolic syndromeShaheena Banu, Nasimudeen R Jabir, C N Manjunath, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 21, 2016
The Use of Azoles Containing Natural Products in Cancer Prevention and Treatment: An OverviewNasimudeen R Jabir, Chelapram K Firoz, Ashish Bhushan, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|December 10, 2015
Cardiovascular disease management through restrained inflammatory responsesNasimudeen R Jabir, Shams Tabrez
Seminars in Cancer Biology|June 22, 2017
An insight on the association of glycation with hepatocellular carcinomaNasimudeen R Jabir, Saheem Ahmad, Shams Tabrez
CNS Neuroscience & Therapeutics|May 18, 2018
Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's diseaseNasimudeen R Jabir, Fayaz Rahman Khan, Shams Tabrez
Journal of Drug Targeting|February 19, 2019
The role of mitochondrial defects and oxidative stress in Alzheimer's diseaseBadar Ul Islam, Nasimudeen R Jabir, Shams Tabrez
Molecular Biology Reports|January 13, 2022
Association of IL-6 promoter polymorphism hotspots (- 174G/C and - 572G/C) with cardiovascular disease risk factorsShams Tabrez, Nasimudeen R Jabir, Torki A Zughaibi, et al.
Molecular Biology Reports|August 25, 2021
Genotyping of interleukins-18 promoters and their correlation with coronary artery stenosis in Saudi populationShams Tabrez, Nasimudeen R Jabir, Torki A Zughaibi, et al.
Critical Reviews in Eukaryotic Gene Expression|November 4, 2019
Association of Plasma Fibrinogen Level with Insulin Resistance in Angiographically Confirmed Coronary Artery Disease PatientsShams Tabrez, Nasimudeen R Jabir, Shazi Shakil, et al.
Biological Chemistry|May 5, 2021
Identification of novel cardiovascular disease associated metabolites using untargeted metabolomicsShams Tabrez, Mohammed Razeeth Shait Mohammed, Nasimudeen R Jabir, et al.
CNS & Neurological Disorders Drug Targets|January 11, 2012
C-peptide and its correlation to parameters of insulin resistance in the metabolic syndromeShaheena Banu, Nasimudeen R Jabir, C N Manjunath, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 21, 2016
The Use of Azoles Containing Natural Products in Cancer Prevention and Treatment: An OverviewNasimudeen R Jabir, Chelapram K Firoz, Ashish Bhushan, et al.
Pageof 6